2012 Ligand Recognition and Molecular Gating Gordon Research Conference

戈登配体识别和分子门控制研究会议将于2012年1月15日至20日在加州文图拉举行。会议的广泛和长期目标是增加我们对完整膜蛋白如何结合或识别配体（离子、小分子、蛋白质）和跨膜传递信号的理解。会议的主要目的是分享离子通道，G蛋白偶联受体和所有类型的转运体的最新知识，重点是将高分辨率结构数据与功能信息相结合，以了解机制。在这三种不同类型的膜蛋白中，一个统一的主题是配体结合、门控和/或运输涉及构象变化。对已定义的、机械相关的全功能蛋白质构象的表征将是2012年会议的重点。该计划将有大约40位演讲者，他们是膜蛋白研究领域的知名领导者以及有前途的年轻研究者。9场会议将广泛讨论参与感觉转导的离子通道、钾通道和谷氨酸受体通道、次级转运体、atp驱动转运体、2-肾上腺素能受体、多巴胺受体和其他gpcr的结构和机制。会议还将讨论膜蛋白结构生物学的新方法和脂质-蛋白相互作用。戈登配体识别和分子门控研究会议的目标是通过汇集该领域一些最重要的科学家来展示和比较结果，讨论新的想法，并建立合作，从而刺激膜蛋白研究领域的进展。

DESCRIPTION: The Gordon Research Conference on Ligand Recognition and Molecular Gating will be held on Jan 15 - 20, 2012, in Ventura, CA. The broad and long term goal of the conference is to increase our understanding of how integral membrane proteins bind or recognize ligands (ions, small molecules, proteins) and transmit signals across membranes. The main objective of the conference is to share the newest knowledge on ion channels, G protein coupled receptors, and transporters of all types, with emphasis on combining high resolution structural data with functional information to understand mechanisms. A unifying theme in these three different classes of membrane proteins is that ligand binding, gating, and/or transport involves conformational changes. The characterization of defined, mechanistically relevant conformations of fully functional protein will be a focus of the 2012 conference. The program will have about 40 speakers, well-established leaders in the field of membrane protein research as well as promising young investigators. Nine sessions will broadly address structure and mechanism of ion channels involved in sensory transduction, potassium channels and glutamate receptor channels, secondary transporters, ATP-driven transporters, 2-adrenergic receptors, dopamine receptors and other GPCRs. There will also be sessions on new approaches for membrane protein structural biology and on lipid-protein interactions. The goal of the Gordon Research Conference on Ligand Recognition and Molecular Gating is to stimulate advances in this area of membrane protein research by bringing together some of the foremost scientists in this community to present and compare results, discuss new ideas, and establish collaborations. PUBLIC HEALTH RELEVANCE: The health relatedness of this application is that well over 50% of current pharmaceutical targets are integral membrane proteins of the types discussed at this conference. Understanding the structure and function of these membrane bound molecules is one of the most important goals of the 21st century, both for science and for development of new therapeutics. Results discussed and new experiments designed have impact on areas such as cancer (ABC transporters), vision/depression/cardiovascular diseases (G-protein coupled receptors), neurodegenerative diseases, skin diseases, deafness, developmental abnormalities and neurological diseases such as epilepsy (ion channels). Disclaimer: Please note that the following critiques were prepared by the reviewers prior to the Study Section meeting and are provided in an essentially unedited form. While there is opportunity for the reviewers to update or revise their written evaluation, based upon the group's discussion, there is no guarantee that individual critiques have been updated subsequent to the discussion at the meeting. Therefore, the critiques may not fully reflect the final opinions of th individual reviewers at the close of group discussion or the final majority opinion of the group. Thus the Resume and Summary of Discussion is the final word on what the reviewers actually considered critical at the meeting.